In the ongoing copyright infringement case brought by The New York Times against OpenAI and Microsoft (The New York Times Company v....

The U.S. Food and Drug Administration (FDA) has been ahead of the curve for a number of years on emerging issues and opportunities for...

In Firstbase.io, Inc. v. Harbor Business Compliance Corporation, No. 24-04043, 2025 Bankr. LEXIS 1092 (Bankr. S.D.N.Y.), the U.S....

Take a quick breath—but just a short one—because late Friday, the Federal Trade Commission (FTC) decided (3-0) to push the compliance...

During the first four months of 2025, at least eight companies listed on the Singapore Exchange (SGX) announced potential delisting and...

The Second Circuit Court of Appeals upheld the dismissal of a proposed class action against Flipps Media (now Triller TV), ruling that...

Admittedly, visions of rainbow-colored carnival taffy or neon sour treats can't help but conjure a sense of childhood nostalgia for at...

Surging interest in artificial intelligence (AI) has sparked a flurry of mergers and acquisitions as companies recognize the technology’s...

Revolve Group, Inc., a popular online fashion retailer, is facing a lawsuit that has brought its influencer marketing practices under the...

In Little Hearts Marks Fam. II L.P. v. Carter (In re 305 E. 61st St. Grp. LLC), 130 F.4th 272 (2d Cir. 2025), the U.S. Court of Appeals...

If you were one of the nearly 15 million viewers tuning in each week to indulge in the escapism of The White Lotus Season 3 set in exotic...

After the Federal Circuit’s January decisions1 affirming the preliminary injunction orders that bar Samsung Bioepis (SB) and Formycon...